Original Research
Published on 18 Jan 2021
“Cerberus” T Cells: A Glucocorticoid-Resistant, Multi-Pathogen Specific T Cell Product to Fight Infections in Severely Immunocompromised Patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2020.608701
- 7,431 views
- 10 citations
